Literature DB >> 22125792

Wnt-pathway activation in intestinal-type sinonasal adenocarcinoma.

Juan Pablo Díaz-Molina1, José Luis Llorente, Blanca Vivanco, Pablo Martínez-Camblor, Manuel Florentino Fresno, Jhudit Pérez-Escuredo, César Álvarez-Marcos, Mario A Hermsen.   

Abstract

BACKGROUND: Intestinal-type sinonasal adenocarcinoma (ITAC) is an epithelial cancer of the sinonasal sinuses that shows histological similarity to colorectal cancer (CRC) and share chronic inflammation as a possible etiological factor. The Wnt-pathway is one of the most important tumourigenic pathways in CRC. The aim of this study was to investigate if the Wnt-pathway is activated in ITAC.
METHODOLOGY: Protein expression profiles of E-cadherin, β-catenin, c-myc and cyclin D1 were analysed by immunohistochemistry in 83 samples of ITAC, organized into tissue microarray blocks.
RESULTS: Nuclear β-catenin expression was observed in 31% of the cases and was twice as frequent in papillary/colonic ITAC compared to solid/mucinous subtypes. Loss of membranous β-catenin staining occurred in 24% and loss of membranous E-cadherin in 6% of the cases and this was more prominent in mucinous types. Strong c-myc and cyclin D1 expression was observed in 30% and 4% of the cases, respectively. Nuclear β-catenin expression was significantly related to poor clinical outcome, independent from established factors as tumour stage and histological type.
CONCLUSION: The presence of nuclear β-catenin in 31% of patients with ITACs indicated that in a subset of patients, the Wnt-pathway is active and conveys a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125792     DOI: 10.4193/Rhino.11.037

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  6 in total

1.  Metastatic behaviour of sinonasal adenocarcinomas of the intestinal type (ITAC).

Authors:  K Donhuijsen; I Kollecker; P Petersen; N Gaßler; J Schulze; H-G Schroeder
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-10       Impact factor: 2.503

Review 2.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

3.  Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma.

Authors:  Paula Sánchez-Fernández; Cristina Riobello; María Costales; Blanca Vivanco; Virginia N Cabal; Rocío García-Marín; Laura Suárez-Fernández; Fernando López; Rubén Cabanillas; Mario A Hermsen; José Luis Llorente
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.

Authors:  Massimo Re; Marco Tomasetti; Federica Monaco; Monica Amati; Corrado Rubini; Giacomo Sollini; Arisa Bajraktari; Federico Maria Gioacchini; Lory Santarelli; Ernesto Pasquini
Journal:  Head Neck       Date:  2021-10-14       Impact factor: 3.821

Review 5.  Malignant Sinonasal Tumors: Update on Histological and Clinical Management.

Authors:  Alessandra Bracigliano; Fabiana Tatangelo; Francesco Perri; Giuseppe Di Lorenzo; Roberto Tafuto; Alessandro Ottaiano; Ottavia Clemente; Maria Luisa Barretta; Nunzia Simona Losito; Mariachiara Santorsola; Salvatore Tafuto
Journal:  Curr Oncol       Date:  2021-07-01       Impact factor: 3.677

Review 6.  Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities.

Authors:  Cecilia Taverna; Abbas Agaimy; Alessandro Franchi
Journal:  Cancers (Basel)       Date:  2022-03-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.